A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
RESPIRATORY PANEL WITH SARS-COV-2 **INHOUSE MOLECULAR TEST**
Test CodeSARSRPANEL
Alias/See Also
RESPIRATORY PANEL WITH COVID-19
**INHOUSE MOLECULAR TEST**
**INHOUSE MOLECULAR TEST**
Includes
SARS-CoV2, ADENOVIRUS, CORONAVIRUS 229, CORONAVIRUS HKU, CORONAVIRUS NL,
CORONAVIRUS OC, METAPNEUMOVIRUS, RHINO/ENTEROV, INFLUENZA A H1,
FLU A H1-2009, INFLUENZA A H3, INFLUENZA B, PARAINFLUENZA 1, PARAINFLUENZA 2,
PARAINFLUENZA 3, PARAINFLUENZA 4, RSV, B PARAPERTUSSIS, B PERTUSSIS,
C. PNEUMONIAE, MYCO PNEUMO
CORONAVIRUS OC, METAPNEUMOVIRUS, RHINO/ENTEROV, INFLUENZA A H1,
FLU A H1-2009, INFLUENZA A H3, INFLUENZA B, PARAINFLUENZA 1, PARAINFLUENZA 2,
PARAINFLUENZA 3, PARAINFLUENZA 4, RSV, B PARAPERTUSSIS, B PERTUSSIS,
C. PNEUMONIAE, MYCO PNEUMO
Preferred Specimen
Nasopharyngeal swab collected in M4 (Viral) Media
Instructions
NASOPHARYNGEAL COLLECTED BY RN OR LABORATORY MLS/MLT
Transport Container
M4 VIRAL TRANSPORT MEDIA
Specimen Stability
Frozen: 1 year
Refrigerated: 72 hours
Room Temp: 24 hours
Refrigerated: 72 hours
Room Temp: 24 hours
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Nasal Saline Specimens
Methodology
Polymerase chain reaction (PCR) - BioFire FilmArray
FDA Status
Emergency Use Authorization
Limitations
This test is performed using rt-PCR for the detection of
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
on the BioFire Respiratory Panel 2.1 assay, BioFire
Diagnostics.
This test has been authorized by the FDA under Emergency Use
Authorization (EUA). Authorization for use is approved until
the public health emergency is terminated or the EUA is
revoked by the FDA.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
on the BioFire Respiratory Panel 2.1 assay, BioFire
Diagnostics.
This test has been authorized by the FDA under Emergency Use
Authorization (EUA). Authorization for use is approved until
the public health emergency is terminated or the EUA is
revoked by the FDA.
Reference Range
Negative
Clinical Significance
The BioFire SARS Respiratory panel is a real-time, nested multiplexed polymerase chain reaction test designed to simultaneously identify nucleic acids from 21 different viruses and bacteria associated with respiratory tract infections, including SARS-CoV-2, from a single nasopharyngeal swab specimen.
Performing Laboratory
LMH-Microbiology